Skip to main content

The independent source for health policy research, polling, and news.

Subscribe Follow Us Donate
  • Trump 2.0

    Trump 2.0

    • Agency Watch
    • State Watch
    • Medicaid Watch
    • Rural Health Payout
  • Public Health

    Public Health

    • Vaccines
    • CDC & Disease
    • Environmental Health
  • Audio Reports

    Audio Reports

    • What the Health?
    • Health Care Helpline
    • KFF Health News Minute
    • An Arm and a Leg
    • Health Hub
    • HealthQ
    • Silence in Sikeston
    • Epidemic
    • See All Audio
  • Special Reports

    Special Reports

    • Bill Of The Month
    • The Body Shops
    • Broken Rehab
    • Deadly Denials
    • Priced Out
    • Dead Zone
    • Diagnosis: Debt
    • Overpayment Outrage
    • Opioid Settlement Tracking
    • See All Special Reports
  • More Topics

    More Topics

    • Elections
    • Health Care Costs
    • Insurance
    • Prescription Drugs
    • Health Industry
    • Immigration
    • Reproductive Health
    • Technology
    • Rural Health
    • Race and Health
    • Aging
    • Mental Health
    • Affordable Care Act
    • Medicare
    • Medicaid
    • Children’s Health

  • High Postcancer Medical Bills
  • Federal Workers’ Health Data
  • Cyberattacks on Hospitals
  • ‘Cheap’ Insurance

Morning Briefing

Summaries of health policy coverage from major news organizations

  • Email

Tuesday, Aug 25 2020

Full Issue

Learning To Live With The Virus Doesn’t Have To Be Scary

Scientists map out scenarios of how humans might come to coexist with this new threat. News looks at developing immunity, retesting's value, and more.

Stat: Four Scenarios On How We Might Develop Immunity To Covid-19

As the world wearies of trying to suppress the SARS-CoV-2 virus, many of us are wondering what the future will look like as we try to learn to live with it. Will it always have the capacity to make us so sick? Will our immune systems learn — and remember — how to cope with the new threat? Will vaccines be protective and long-lasting? (Branswell, 8/25)

CIDRAP: Study Suggests Limited Diagnostic Value For Repeat COVID-19 Testing

Of 10,165 patients tested for COVID-19 at a large Los Angeles health system, 6.2% were positive, and only 1.9% tested positive after an initial negative result—calling into question the diagnostic value of repeat testing amid limited testing resources, according to a retrospective study published late last week in the International Journal of Infectious Diseases. Researchers analyzed all test results for SARS-CoV-2, the virus that causes COVID-19, at the UCLA Health System from Mar 9 to Apr 29 to understand the diagnostic yield of repeat testing in view of scarce test supplies and personal protective equipment. (8/24)

Kaiser Health News: Analysis: You’ve Checked For Fever. Now, What’s Your Risk Tolerance? 

As some parts of America gingerly begin to open up after months of near-total lockdown, people have questions. Will it be safe to take a train? A plane? Visit the hair salon? An indoor restaurant? There are many knowable parameters in the equation: your health; the prevalence of cases where you live; the safety precautions being taken anyplace you want to visit. But the final answer may depend on your individual risk tolerance for exposure to infectious disease. (Rosenthal, 8/25)

This is part of the Morning Briefing, a summary of health policy coverage from major news organizations. Sign up for an email subscription.
Newsletter icon

Sign Up For Our Newsletter

Stay informed by signing up for the Morning Briefing and other emails:

Recent Morning Briefings

  • Tuesday, April 21
  • Monday, April 20
  • Friday, April 17
  • Thursday, April 16
  • Wednesday, April 15
  • Tuesday, April 14
More Morning Briefings
RSS Feeds
  • Podcasts
  • Special Reports
  • Morning Briefing
  • About Us
  • Donate
  • Staff
  • Republish Our Content
  • Contact Us

Follow Us

  • Instagram
  • YouTube
  • LinkedIn
  • Facebook
  • X
  • Bluesky
  • TikTok
  • RSS

Sign up for emails

Join our email list for regular updates based on your personal preferences.

Sign up
  • Editorial Policy
  • Privacy Policy

© 2026 KFF